Article
Integrated Multi-Omics Signature Predicts Survival in Head and Neck Cancer
16 Aug 2022
Abstract excerpt
Head and Neck Cancer (HNC) is characterized by phenotypic, biological, and clinical heterogeneity. Despite treatment modalities, approximately half of all patients will die of the disease. Several molecular biomarkers have been investigated, but until now, without clinical translation. Here, we identified an integrative nine-gene multi-omics signature correlated with HNC patients' survival independently of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
